Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 8, 2007, Pages 1776-1781

  Jankowski, Vera ^a   Meyer, Andreas Alexander ^b   Schlattmann, Peter ^a   Gui, Yu ^c   Zheng, Xi Long ^a   Stamcou, Irini ^a   Radtke, Kristina ^b   Anh Tran, Thi Nguyet ^a   Van Der Giet, Markus ^a   Tölle, Markus ^a   Zidek, Walter ^a   Jankowski, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Hypertension; Plasma concentration; Proliferation; Uridine adenosine tetraphosphate

Indexed keywords

ADENOSINE DERIVATIVE; ADENOSINE PHOSPHATE; UNCLASSIFIED DRUG; URIDINE ADENOSINE TETRAPHOSPHATE; BIOLOGICAL MARKER; URIDINE;

ADOLESCENT; AFFINITY CHROMATOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN CELL; HYPERTENSION; MALE; MUSCLE CELL; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VASCULAR SMOOTH MUSCLE; AGE; BLOOD; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; URIDINE;

EID: 34547624084     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.143958     Document Type: Article

References (29)

1. Jankowski V, Tölle M, Vanholder R, Schönfelder G, van der Giet M, Henning L, Schlüter H, Paul M, Zidek W, Jankowski J. Identification of uridine adenosine tetraphosphate (Up4A) as an endothelium-derived vasoconstrictive factor. Nature Medicine. 2005;11:223-227.
2. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996;98:649-658.
3. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, Krull F, Reichert H, Reusz GS, Rascher W. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr. 1997;130:178-184.
4. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
5. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613-618.
6. Barnes LD, Robinson AK, Mumford CH, Garrison PN. Assay of diadenosine tetraphosphate hydrolytic enzymes by boronate chromatography. Anal Biochem. 1985;144:296-304.
7. Gui Y, Zheng XL. Epidermal growth factor induction of phenotypedependent cell cycle arrest in vascular smooth muscle cells is through the mitogen-activated protein kinase pathway. J Biol Chem. 2003;278:53017-53025.
8. King BF, Liu M, Pintor J, Gualix J, Miras-Portugal MT, Burnstock G. Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors. Br J Pharmacol. 1999;128:981-988.
9. Miras-Portugal MT, Diaz-Hernandez M, Gomez-Villafuerte R, Gualix J, Castro E, Pintor J. Presynaptic signalling mediated by mono- and dinucleotides in the central nervous system. J Auton Nerv Syst. 2000;81:195-199.
10. Communi D, Motte S, Boeynaems JM, Pirotton S. Pharmacological characterization of the human P2Y4 receptor. Eur J Pharmacol. 1996;317:383-389.
11. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413-492.
12. Erlinge D. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol. 1998;31:1-8.
13. Hou M, Harden TK, Kuhn CM, Baldetorp B, Lazarowski E, Pendergast W, Moller S, Edvinsson L, Erlinge D. UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. Am J Physiol Heart Circ Physiol. 2002;282:H784-H792.
14. Kunapuli SP, Daniel JL. P2 receptor subtypes in the cardiovascular system. Biochem J. 1998;336(Pt 3):513-523.
15. Bogdanov YD, Wildman SS, Clements MP, King BF, Burnstock G. Molecular cloning and characterization of rat P2Y4 nucleotide receptor. Br J Pharmacol. 1998;124:428-430.
16. Greig AV, Linge C, Terenghi G, McGrouther DA, Burnstock G. Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J Invest Dermatol. 2003;120:1007-1015.
17. Pfeilschifter J. Extracellular ATP stimulates polyphosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells. Involvement of a pertussis toxin-sensitive guanine nucleotide binding protein and feedback inhibition by protein kinase C. Cell Signal. 1990;2:129-138.
18. Pfeilschifter J. Comparison of extracellular ATP and UTP signalling in rat renal mesangial cells. No indications for the involvement of separate purino- and pyrimidino-ceptors. Biochem J. 1990;272:469-472.
19. Pavenstadt H, Gloy J, Leipziger J, Klar B, Pfeilschifter J, Schollmeyer P, Greger R. Effect of extracellular ATP on contraction, cytosolic calcium activity, membrane voltage and ion currents of rat mesangial cells in primary culture. Br J Pharmacol. 1993;109:953-959.
20. 2+ response of rat mesangial cells to ATP analogues. Eur J Pharmacol. 1999;369:107-112.
21. Pfeilschifter J, Huwiler A. Regulatory functions of protein kinase C isoenzymes in purinoceptor signalling in mesangial cells. J Auton Pharmacol. 1996;16:315-318.
22. Pfeilschifter J, Merriweather C. Extracellular ATP and UTP activation of phospholipase D is mediated by protein kinase C-epsilon in rat renal mesangial cells. Br J Pharmacol. 1993;110:847-853.
23. Huwiler A, Pfeilschifter J. Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells. Br J Pharmacol. 1994;113:1455-1463.
24. Huwiler A, Rolz W, Dorsch S, Ren S, Pfeilschifter J. Extracellular ATP and UTP activate the protein kinase B/Akt cascade via the P2Y(2) purinoceptor in renal mesangial cells. Br J Pharmacol. 2002;136:520-529.
25. Harper S, Webb TE, Charlton SJ, Ng LL, Boarder MR. Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br J Pharmacol. 1998;124:703-710.
26. Lenz G, Gottfried C, Luo Z, Avruch J, Rodnight R, Nie WJ, Kang Y, Neary JT. P(2Y) purinoceptor subtypes recruit different mek activators in astrocytes. Br J Pharmacol. 2000;129:927-936.
27. Neary JT, Kang Y, Willoughby KA, Ellis EF. Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J Neurosci. 2003;23:2348-2356.
28. Greenberg S, Gaines K, Sweatt D. Evidence for circulating factors as a cause of venous hypertrophy in spontaneously hypertensive rats. Am J Physiol. 1981;241:H421-H430.
29. Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, H SA, Meurer S, Deile M, Taye A, Knorr A, Lapp H, Muller H, Turgay Y, Rothkegel C, Tersteegen A, Kemp-Harper B, Muller-Esterl W, Schmidt HH. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest. 2006;116:2552-2561.